Submission Details
| 510(k) Number | K931465 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 24, 1993 |
| Decision Date | July 06, 1993 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Statement |
K931465 is an FDA 510(k) clearance for the REP ALKALINE HB-15 #3196,-8 #3197,-4 3198, a System, Analysis, Electrophoretic Hemoglobin (Class II — Special Controls, product code JBD), submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on July 6, 1993, 104 days after receiving the submission on March 24, 1993. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7440.
| 510(k) Number | K931465 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 24, 1993 |
| Decision Date | July 06, 1993 |
| Days to Decision | 104 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Statement |
| Product Code | JBD — System, Analysis, Electrophoretic Hemoglobin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7440 |